Get the Stockscreener App
20.69
4.55%
0.90
After Hours:
21.00
0.31
+1.50%
Tectonic Therapeutic Inc stock is traded at $20.69, with a volume of 310.01K.
It is up +4.55% in the last 24 hours and down -0.39% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$19.79
Open:
$19.77
24h Volume:
310.01K
Relative Volume:
0.80
Market Cap:
$387.24M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+8.61%
1M Performance:
-0.39%
6M Performance:
-7.26%
1Y Performance:
-19.56%
1-Day Range:
$19.54
$21.00
1-Week Range:
$18.78
$21.00
52-Week Range:
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
20.69 | 370.40M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.68 | 121.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.44 | 78.94B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
847.72 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
346.79 | 46.18B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
350.00 | 38.73B | 4.98B | 69.59M | 525.67M | 0.5197 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Sep-03-25 | Initiated | Oppenheimer | Outperform |
| Jul-21-25 | Initiated | Truist | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-21-25 | Initiated | Mizuho | Outperform |
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
Breakouts Watch: Is Sprott Focus Trust Inc in a consolidation phase2025 Key Highlights & Real-Time Price Movement Reports - baoquankhu1.vn
Published on: 2026-01-26 00:19:05 - baoquankhu1.vn
Can Tectonic Therapeutic Inc lead its sector in growthQuarterly Trade Report & Verified Entry Point Detection - baoquankhu1.vn
Tectonic Therapeutic Reports Q3 2025 Financial Results - MSN
Stock Report: What is Westwater Resources Incs valuation compared to sectorEarnings Risk Report & Growth Focused Stock Pick Reports - baoquankhu1.vn
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Why Tectonic Therapeutic Inc. stock could benefit from AI revolution2025 Short Interest & Weekly Top Performers Watchlists - bollywoodhelpline.com
Quarterly Recap: Will Tectonic Therapeutic Inc benefit from current market trendsWeekly Market Outlook & Accurate Trade Setup Notifications - baoquankhu1.vn
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unveiling a Potential 300% Upside in Biotech Investment - DirectorsTalk Interviews
Sentiment Watch: What are analysts price targets for Tectonic Therapeutic IncTrade Entry Report & Expert Curated Trade Setups - baoquankhu1.vn
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 0.8%Time to Sell? - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 0.8% – Time to Sell? - Defense World
Sectors Review: What Wall Street predicts for Tectonic Therapeutic Inc stock price2025 Top Gainers & Community Shared Stock Ideas - Bộ Nội Vụ
Returns Recap: What are Tectonic Therapeutic Incs recent SEC filings showingJuly 2025 PreEarnings & Expert Approved Trade Ideas - baoquankhu1.vn
Hedge Fund Bets: Is Tectonic Therapeutic Inc a stock for growth or value investorsWeekly Volume Report & Trade Opportunity Analysis - baoquankhu1.vn
Analyst Upgrade: Is Tectonic Therapeutic Inc stock a falling knife or bargain buy2025 Market Sentiment & Community Consensus Stock Picks - baoquankhu1.vn
Breakout Move: Can Tectonic Therapeutic Inc stock sustain institutional interest2025 AllTime Highs & Fast Gain Swing Alerts - Bộ Nội Vụ
MSN Money - MSN
Truist Financial Sticks to Their Buy Rating for Tectonic Therapeutic (TECX) - The Globe and Mail
Will Tectonic Therapeutic Inc. stock return to pre crisis levelsMarket Trend Report & Free High Accuracy Swing Entry Alerts - Улправда
Is Tectonic Therapeutic Inc. stock a defensive play in 2025Weekly Earnings Recap & Weekly Sector Rotation Insights - ulpravda.ru
Can Tectonic Therapeutic Inc. stock sustain institutional interestMarket Performance Recap & Weekly Watchlist of Top Performers - ulpravda.ru
Why Tectonic Therapeutic Inc. stock is popular among millennials2025 Big Picture & Weekly Market Pulse Updates - Улправда
Is Tectonic Therapeutic Inc. stock attractive for ETFsTrade Performance Summary & Reliable Price Breakout Signals - Улправда
Will Tectonic Therapeutic Inc. stock recover faster than peersJuly 2025 Technicals & Safe Capital Allocation Plans - Улправда
Can Tectonic Therapeutic Inc. stock beat analyst upgradesQuarterly Market Summary & Daily Entry Point Trade Alerts - Улправда
TECTONIC THERAPEUTIC, INC. (TECX) - MSN
Tectonic Therapeutic (TECX): LifeSci Capital reiterates buy rating - MSN
Analysts Are Bullish on Top Healthcare Stocks: Tectonic Therapeutic (TECX), Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Hopeful Week For Insiders Who Bought US$51.1m Of Tectonic Therapeutic Stock - 富途牛牛
Tectonic Therapeutic Earnings Notes - Trefis
Can Tectonic Therapeutic Inc. stock deliver strong Q4 earnings2025 AllTime Highs & Verified Technical Trade Signals - Улправда
Will Tectonic Therapeutic Inc. stock benefit from green energy trendsJuly 2025 Institutional & Verified Technical Trade Signals - Улправда
Is Tectonic Therapeutic Inc. stock attractive after correctionJuly 2025 Decliners & Low Risk Entry Point Tips - DonanımHaber
Tectonic Therapeutic (TECX) Receives a Buy from Wells Fargo - The Globe and Mail
Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating - Finviz
11 Best Micro-Cap Stocks to Invest in According to Analysts - Insider Monkey
Will Tectonic Therapeutic Inc. stock continue upward momentumProfit Target & Community Consensus Trade Alerts - Newser
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives $82.17 Average Target Price from Brokerages - Defense World
Tectonic Therapeutic (TECX) Stock Analysis Report | Financials & Insights - Benzinga
Tectonic Therapeutic to Participate in December Investor Conferences - The Manila Times
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Its Stock Has Paid Off Big Time For Tectonic Therapeutic Inc - Setenews
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Tectonic Therapeutic Inc Stock (TECX) Financials Data
There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.89%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):